Use of eHealth in the management of pulmonary arterial hypertension: review of the literature.


Journal

BMJ health & care informatics
ISSN: 2632-1009
Titre abrégé: BMJ Health Care Inform
Pays: England
ID NLM: 101745500

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 14 05 2020
revised: 12 06 2020
accepted: 29 06 2020
entrez: 15 9 2020
pubmed: 16 9 2020
medline: 24 7 2021
Statut: ppublish

Résumé

Pulmonary arterial hypertension (PAH) is a severe chronic condition associated with poor quality of life and high risks of mortality and hospitalisation. The utilisation of novel diagnostic technologies has improved survival rates although the effectiveness of Electronic Health (eHealth) interventions in patients with a chronic cardiopulmonary disease remains controversial. As the effectiveness of eHealth can be established by specific evaluation for different chronic health conditions, the aim of this study was to explore and summarise the utilisation of eHealth in PAH. We searched PubMed, CINAHL and Embase for all studies reporting clinical trials on eHealth solutions for the management of PAH. No limitations in terms of study design or date of publication were imposed. 18 studies (6 peer-reviewed journal papers and 12 conference papers) were identified. Seven studies addressed the accuracy, safety or reliability of eHealth technologies such as intra-arterial haemodynamic monitoring of the pulmonary artery pressure, self-administered 6-Minute walk test App, computerised step-pulse oximeter and ambulatory impedance cardiography. Two studies evaluated eHealth as part of the medical management and showed a reduction in hospitalisation rate. The evidence of eHealth supporting the management of people with PAH is limited and only embraced through a few studies of small sample size and short-term duration. Given the proposed clinical benefits in heart failure, we postulate that the evaluation of eHealth for the clinical management of PAH is highly warranted.

Sections du résumé

BACKGROUND BACKGROUND
Pulmonary arterial hypertension (PAH) is a severe chronic condition associated with poor quality of life and high risks of mortality and hospitalisation. The utilisation of novel diagnostic technologies has improved survival rates although the effectiveness of Electronic Health (eHealth) interventions in patients with a chronic cardiopulmonary disease remains controversial. As the effectiveness of eHealth can be established by specific evaluation for different chronic health conditions, the aim of this study was to explore and summarise the utilisation of eHealth in PAH.
METHOD METHODS
We searched PubMed, CINAHL and Embase for all studies reporting clinical trials on eHealth solutions for the management of PAH. No limitations in terms of study design or date of publication were imposed.
RESULTS RESULTS
18 studies (6 peer-reviewed journal papers and 12 conference papers) were identified. Seven studies addressed the accuracy, safety or reliability of eHealth technologies such as intra-arterial haemodynamic monitoring of the pulmonary artery pressure, self-administered 6-Minute walk test App, computerised step-pulse oximeter and ambulatory impedance cardiography. Two studies evaluated eHealth as part of the medical management and showed a reduction in hospitalisation rate.
CONCLUSIONS CONCLUSIONS
The evidence of eHealth supporting the management of people with PAH is limited and only embraced through a few studies of small sample size and short-term duration. Given the proposed clinical benefits in heart failure, we postulate that the evaluation of eHealth for the clinical management of PAH is highly warranted.

Identifiants

pubmed: 32928780
pii: bmjhci-2020-100176
doi: 10.1136/bmjhci-2020-100176
pmc: PMC7490940
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 BMJ Publishing Group Ltd & BCS, the Chartered Institute for IT. All rights reserved.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Chest. 2003 Jul;124(1):351-9
pubmed: 12853544
Int J Chron Obstruct Pulmon Dis. 2018 Aug 29;13:2657-2662
pubmed: 30214183
J Telemed Telecare. 2014 Jan;20(1):44-55
pubmed: 24352897
J Telemed Telecare. 2016 Jul;22(5):282-95
pubmed: 26350543
Eur Respir Rev. 2016 Dec;25(142):408-417
pubmed: 27903663
Chest. 2013 Feb 1;143(2):333-343
pubmed: 22922554
J Med Internet Res. 2018 May 01;20(5):e10235
pubmed: 29716883
Cochrane Database Syst Rev. 2015 Sep 07;(9):CD002098
pubmed: 26343551
J Natl Cancer Inst. 1992 Apr 15;84(8):575-9
pubmed: 1556768
Health Informatics J. 2011 Dec;17(4):247-55
pubmed: 22193825
J Med Internet Res. 2005 Mar 31;7(1):e9
pubmed: 15829481
Eur Respir Rev. 2010 Sep;19(117):204-11
pubmed: 20956193
J Am Coll Cardiol. 2015 Apr 28;65(16):1668-1682
pubmed: 25908073
Heart. 2014 Nov;100(22):1770-9
pubmed: 24973083
Lancet. 2018 Sep 22;392(10152):1047-1057
pubmed: 30153985
Arch Bronconeumol. 2008 Feb;44(2):87-99
pubmed: 18361875
Br J Gen Pract. 2014 Jul;64(624):e392-400
pubmed: 24982491
Popul Health Manag. 2015 Aug;18(4):246-55
pubmed: 25607246
Clin Res Cardiol. 2013 Jan;102(1):51-61
pubmed: 22875547
Annu Int Conf IEEE Eng Med Biol Soc. 2012;2012:2178-81
pubmed: 23366354
Ther Adv Chronic Dis. 2017 Feb;8(2-3):47-64
pubmed: 28348727
Eur Respir Rev. 2015 Dec;24(138):621-9
pubmed: 26621976
J Med Internet Res. 2017 Jan 20;19(1):e18
pubmed: 28108430
Circ Res. 2014 Jun 20;115(1):115-30
pubmed: 24951762
Circ Heart Fail. 2015 Sep;8(5):905-13
pubmed: 26283292
J Am Coll Cardiol. 2009 Apr 28;53(17):1573-619
pubmed: 19389575
Respirology. 2011 Nov;16(8):1235-40
pubmed: 21810146
Interact J Med Res. 2012 Sep 24;1(2):e9
pubmed: 23612055
Stud Health Technol Inform. 2012;180:25-9
pubmed: 22874145
Cochrane Database Syst Rev. 2015 Oct 31;(10):CD007228
pubmed: 26517969
J Heart Lung Transplant. 2015 Mar;34(3):329-37
pubmed: 24999252
Lancet. 2011 Feb 19;377(9766):658-66
pubmed: 21315441
J Telemed Telecare. 2014 Mar;20(2):102-12
pubmed: 24614997
J Telemed Telecare. 2013 Dec;19(8):479-86
pubmed: 24197398
Physiol Rep. 2014 Jun 11;2(6):
pubmed: 24920122
Lancet Respir Med. 2016 Apr;4(4):241
pubmed: 27304365

Auteurs

Manuel C Gonzalez-Garcia (MC)

Department of Epidemiology and Global Health, Faculty of Medicine, Umeå University, Umeå, Sweden.
Australian e-Health Research Centre, CSIRO, Brisbane, Queensland, Australia.

Farhad Fatehi (F)

Centre for Online Health, The University of Queensland, Brisbane, Queensland, Australia ffatehi@gmail.com.
School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Marlien Varnfield (M)

Australian e-Health Research Centre, CSIRO, Brisbane, Queensland, Australia.

Hang Ding (H)

Australian e-Health Research Centre, CSIRO, Brisbane, Queensland, Australia.
RECOVER Injury Research Centre, The University of Queensland, Herston, Queensland, Australia.

Mohan Karunanithi (M)

Australian e-Health Research Centre, CSIRO, Brisbane, Queensland, Australia.

Ian Yang (I)

Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, Queensland, Australia.
Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia.

Rachael Cordina (R)

Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.

John Feenstra (J)

Queensland Lung Transplant Service, The Prince Charles Hospital, Chermside, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH